Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NUS1 pseudogene 4 (NUS1P4) is classified as a pseudogene of the NUS1 (Nogo-B receptor) gene family and is annotated in public genome databases as a non-coding gene without known protein product or function[5]. Unlike the functional NUS1 gene, which encodes a receptor subunit involved in dolichol synthesis and is implicated in neural and metabolic disorders[1][4], NUS1P4 simply represents a duplicated, likely inactive segment of DNA. While some pseudogenes can regulate their parent genes through noncoding RNA mechanisms or serve as genetic reservoirs[3], there is currently no evidence in databases or the literature that NUS1P4 has such a role. It is not considered a therapeutic target or associated with any drugs, mechanisms of action, clinical biomarkers, or specific safety concerns[5]. Relevant database identifiers for NUS1P4: - HGNC: 38474 - NCBI Gene: 100130167 - Ensembl: ENSG00000217686[5] In summary, NUS1P4 is a pseudogene with no established biological or therapeutic relevance beyond its relationship to the functional NUS1 gene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NUS1 pseudogene 4 (NUS1P4).